Supplementary file - Efficacy and safety of methotrexate add-on therapy versus placebo for patients with chronic spontaneous urticaria resistant to H1-antihistamines: a randomized, controlled trial

Published: 30 July 2019| Version 1 | DOI: 10.17632/82k28wzxmr.1
Contributor:
Sophie Leducq

Description

Supplementary data for the publication by Leducq S. et al. Efficacy and safety of methotrexate add-on therapy versus placebo for patients with chronic spontaneous urticaria resistant to H1-antihistamines: a randomized, controlled trial. J Am Acad Dermatol 2019.

Files

Institutions

Centre Hospitalier Regional Universitaire de Tours

Categories

Dermatology, Urticaria, Antihistamine, Methotrexate

Licence